The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.
Qinggang Wang
Advertisement
Qinggang Wang is a principal scientist at Bristol-Myers Squibb, qinggang.wang@bms.com.
Articles by Qinggang Wang
A risk-based approach is recommended for analytical method comparability for HPLC assay and impurities methods.
Advertisement
Latest Updated Articles
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based ApproachPublished: October 2nd 2014 | Updated:
Evaluating Progress in Analytical Quality by DesignPublished: April 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360 2025: Trends in Bioanalysis
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
